---
deliverable_id: folio-watch-v1-4-0
phase: B.1
role: alignment
family: codex
status: completed
evidence_labels_used:
  - direct-run
---

# B.1 Alignment Review: folio-watch-v1-4-0

## Verdict
approve

## Scope Reviewed

This review is limited to the Phase A specification, the strict-P3 Pre-A triage record, and the manifest for `folio-watch-v1-4-0`:

- `docs/validation/strict_p3_rerun_2026_05_12/pre_a_triage.md`
- `docs/validation/strict_p3_rerun_2026_05_12/folio-watch-v1-4-0_phase_a_spec.md`
- `frameworks/manifests/folio-watch-v1-4-0.yaml`

## Alignment Assessment

The Phase A spec is adequate to drive this slice. It identifies issue #62 as the scope authority, points to the regenerated strict-P3 triage artifact, and explicitly states that prior `folio_*_v1_*` artifacts are not lifecycle evidence. Its acceptance criteria cover the core watch/drop-zone behavior needed for the slice: `folio watch <dir>`, `--once`, `--dry-run`, `--quiet`, extension routing, stable file-size waiting, serial processing, success archiving, and `_failed/` failure handling.

The manifest aligns with that scope. Its summary matches the spec, its `pre_a.artifact_path` points at the strict-P3 triage file, and its allowed implementation surface covers `folio/watch.py`, `folio/cli.py`, and `tests/test_watch.py`. The review-board artifact pattern covers this B.1 artifact and the later family review artifacts. The model assignments correctly place Codex in the B.1 alignment role and retain independent peer and adversarial reviewers.

## Evidence Hygiene

The lifecycle wiring is sufficient to prevent stale evidence reuse. The spec rejects old failed-closeout artifacts as evidence, and the manifest routes lifecycle outputs to `docs/validation/strict_p3_rerun_2026_05_12/` plus the slice-specific receipt inventory. Required validation includes both focused tests and strict lifecycle verification, with an explicit negative control requiring `verify-lifecycle` to fail with `review_pending` before receipts exist.

No blocker was found in the Phase A spec or manifest that would prevent Phase C from proceeding under strict-P3 controls.
